Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.

Scott Baker, the Functional and Systems Biology Group leader at PNNL, has been named to the American Institute for Medical and Biological Engineering's Class of 2024 Fellows.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

PNNL wins seven R&D 100 awards – total tops 100